|
Erin Kutz joins Xconomy with a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
She started her career as a management consultant, but Aubrie Pagano says she always knew she wanted to be an entrepreneur. And she was particularly energized by fashion.
So Pagano spent her free... Read more »
Plans for IPOs and venture funding dominated the New England deals news this week.
—A new seed fund, backed by venture firm New Enterprise Associates and hosted by Harvard, came out of... Read more »
News of FDA drug approvals shone the spotlight on some New England biotechs this week.
—Waltham, MA-based Alkermes (NASDAQ: ALKS) and San Diego-based Amylin Pharmaceuticals(NASDAQ: AMLN) won FDA approval for... Read more »
Snapette was supposed to be an unusual way for Sarah Paiji to spend the summer between her two years at Harvard Business School. It was a mobile app idea she started working... Read more »
This week’s deal news covered a breadth of sectors: biotech, medical devices, mobile applications, software, and robotics. Not to mention a major venture capital fund raise.
—Waltham, MA-based drugmaker Avila Therapeutics was bought by... Read more »
The blow from getting a higher-than-expected bill from someone like your lawyer could be softened it if came attached to a 60-second video message explaining the special things he or she actually did... Read more »
Burlington, MA-based ConforMIS, a medical device company with a newly FDA approved knee replacement system, announced today that it has secured $89 million in a Series E investment.
The money comes from London-based AGC Equity... Read more »
It was a busy news week in the New England life sciences scene, with acquisitions, clinical data, and partnership deals.
—Thanks to a new co-promotion deal, Genzyme will begin marketing a diagnostic test for... Read more »
Mark Lowenstein has made some pretty bold statements about what’s going to happen in the wireless industry this year. More mergers and acquisitions among mobile operators. Same goes for the handset... Read more »
An acquisition and startup financings made up the New England deals news this week.
—Waltham, MA-based marketing software firm Constant Contact acquired the Boston startup CardStar, the developer of a mobile app... Read more »
Boston has no place for “serious, venture-backed startups” to grow from five employees to 25 employees, akin to San Francisco’s RocketSpace, or New York City’s General Assembly, says Mark Kasdorf.... Read more »
The vast majority of mobile applications in the marketplace aren’t coming from well-established businesses, but experimental developers. The apps can even accrue a good user following, but those developers don’t exactly have... Read more »
“Money is money, anyone can do that,” says Brian Zimmerman, managing director of Boston-based OpenView Venture Partners.
Go on.
“We have this idea of providing real value to our portfolio companies. If... Read more »
Web startups, venture firms, life sciences companies, and a biofuels developer rounded out the deals news this week.
—Cambridge, MA-based Flagship Ventures announced it had closed a $270 million fund, surpassing the... Read more »
Yesterday Bob told you about a special report we put together by canvassing the Xconomists—some of the world’s leading innovators, entrepreneurs, and investors—for their thoughts on what students should study to... Read more »
Joule Unlimited, a biofuels startup located in Bedford, MA, announced today that it has pocketed $70 million in financing to put toward a facility underway in Hobbs, NM, that will demonstrate Joule’s... Read more »
Development deals, clinical advances, startup funding, and new hires made up the New England life sciences news this week.
—Chelsea, MA-based Civitas Therapeutics, a spinout from the Waltham, MA, biotech Alkermes (NASDAQ: ALKS... Read more »
Boston area software and life sciences startups are starting off the new year right with a slew of financing, acquisitions, and partnerships news.
—Marlborough, MA-based Physicians Interactive Holdings received a $17 million... Read more »
For almost two years, Pyxis Mobile has been restructuring its business to sell platforms for mobile app development, but was lacking the capital to make the switch official, says CEO Steven... Read more »
[Updated 1/11/12 5:15 pm. See below.] “Sermo has been my baby, my blood and tears,” its former CEO Daniel Palestrant told me in a phone call last week.
So it was... Read more »
Xconomy offers a number of ways to subscribe for free!
Subscribe NowBusiness, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.